Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-07

Clinical Trial Update: TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers [NA]

View source ↗

Summary

Clinical trial update evaluating TheraGauze alone and with Regranex Gel 0.01% for Wagner Stage I diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Regranex Gel 0.01% (becaplermin)
  • TheraGauze

Snippet

Sponsor: Solsys Medical LLC | Conditions: Diabetic Foot Ulcer | NA | Status: UNKNOWN